Gastric per-oral endoscopic myotomy: Current status and future directions

查看全文 作　　者：Alexander [1]Podboy;Joo Ha [1]Hwang;Linda A [1]Nguyen;Patricia [1]Garcia;Thomas A [1]Zikos;Afrin [1]Kamal;George [1]Triadafilopoulos;John O [1]Clarke

机构地区：[1]Division of Gastroenterology and Hepatology,Stanford University School of Medicine

出　　处：《World Journal of Gastroenterology》索引2019年第25卷第21期,共10页

摘　　要：Gastroparesis, or symptomatic delayed gastric emptying in the absence of mechanical obstruction, is a challenging and increasingly identified syndrome. Medical options are limited and the only medication approved by the Food and Drug Administration for treatment of gastroparesis is metoclopramide, although other agents are frequently used off label. With this caveat, first-line treatments for gastroparesis include dietary modifications, antiemetics and promotility agents, although these therapies are limited by suboptimal efficacy and significant medication side effects. Treatment of patients that fail first-line treatments represents a significant therapeutic challenge. Recent advances in endoscopic techniques have led to the development of a promising novel endoscopic therapy for gastroparesis via endoscopic pyloromyotomy, also referred to as gastric per-oral endoscopic myotomy or per-oral endoscopic pyloromyotomy. The aim of this article is to review the technical aspects of the per-oral endoscopic myotomy procedure for the treatment of gastroparesis, provide an overview of the currently published literature, and outline potential next directions for the field. 关键词：Gastroparesis GASTRIC per-oral ENDOSCOPIC MYOTOMY Per-oral ENDOSCOPIC PYLOROMYOTOMY MYOTOMY ENDOSCOPIC MYOTOMY Peroral ENDOSCOPIC MYOTOMY GASTRIC emptying

相关文献

参考文献（45）
引证文献（5）
耦合文献（0）

参考文献(45)

引证文献(5)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Gastric per-oral endoscopic myotomy: Current status and future directions

参考文献(45)

引证文献(5)

用户提示